Artificial Organ Market, By Organ Type (Artificial Heart (Ventricular Assist Devices (VADs), Total Artificial Hearts (TAHs)), Artificial Kidney (Wearable Artificial Kidneys, Implantable Renal Devices), Artificial Liver (Bioartificial Liver Support Systems, Artificial Pancreas, Artificial Lungs, Sensory Organs, Corneal Implants, and Others (Neuro-Controlled Prostheses)), By Patient Type (Neonates, Pediatric, and Adult), By End User (Hospitals, Transplant Centers, Ambulatory Surgical Centers, Emergency and Trauma Centers, Home Care Settings, and Others (Research Institutes, etc.)), By Application (Transplantation, Chronic Disease Management, and Other Emergency or Acute Care), By Technology (Mechanical, Electronic or Bionic, Biomechanical Hybrid, Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues), and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)